[Federal Register Volume 88, Number 91 (Thursday, May 11, 2023)]
[Notices]
[Page 30320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10008]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Institute Council of Research Advocates.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The meeting can be accessed from the NIH
Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: National Cancer Institute Council of Research
Advocates.
Date: June 21, 2023.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: Welcome and Chairwoman's Remarks, NCI Director's Update,
NCI Updates and Legislative Update.
Place: National Institutes of Health, 9000 Rockville Pike,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Amy Williams, Acting Director, NCI, Office of
Advocacy Relations, National Cancer Institute, NIH, 31 Center Drive,
Building 31, Room 10A28, Bethesda, MD 20892, (301) 496-9723,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: NCRA: http://deainfo.nci.nih.gov/advisory/ncra/ncra.htm, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-10008 Filed 5-10-23; 8:45 am]
BILLING CODE 4140-01-P